Dr. Reddy's Laboratories Ltd. closed 18.89% below its 52-week high of 1,420.20 rupees, which the company reached on August ...

Dr. Reddy's Laboratories Ltd. closed 17.55% below its 52-week high of 1,420.20 rupees, which the company achieved on August ...

Allspring Global Investments Holdings LLC grew its holdings in Dr. Reddy’s Laboratories Limited (NYSE:RDY – Free Report) by ...

View Our Latest Report on Dr. Reddy’s Laboratories Dr. Reddy’s Laboratories Trading Down 0.3 % NYSE RDY opened at $13.57 on Wednesday. The company has a current ratio of 1.92, a quick ratio of ...

Dr. Reddy’s has entered into a license agreement with Shanghai Henlius Biotech related to the development and ...

Dr Reddy's Labs has experienced a notable decline from its peak of Rs 1,406, nearing the key support level of Rs 1,120, which has historically acted as a strong floor, often triggering a pullback.

An analyst from YES Securities said that Vedanta has faced downward pressure, leading to a gradual decline in its stock price ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Hyderabad: Labour leaders and politicians from across the spectrum praised Dr G. Sanjeeva Reddy, president of the Indian National Trade Union Congress (Intuc), for his 75 years of relentless ...

In the face of looming revenue decline from blood cancer medication Revlimid, Indian pharma companies Natco Pharma and Dr.

31 May, 2006 28 Aug, 2006 1:1 For every 1 share held; Holder will receive 1 bonus shares. 24 Mar, 1994 08 Apr, 1994 2:1 For every 1 share held; Holder will receive 2 bonus shares. 30 Sep, 1992 04 ...